Kyntra Bio, Inc.
Market Cap
$29.21M
P/E Ratio
-2.38
EPS
$-3.04
Dividend Yield
0.00%
52-Week Range
$0.34 — $20.80
Volume
918
Avg Volume
28.08K
Beta
0.90
Get alerted when 0IL8.L hits your target price.
Free — enter your email to get started
P/E (TTM)
-2.38
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
4.50
P/B (TTM)
6.48
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.62%
ROA (TTM)
1.53%
ROIC
—
Gross Margin
0.76%
Operating Margin
-7.13%
Net Margin
—
Debt/Equity
0.00
Current Ratio
3.39
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.30%
EPS Growth (5Y)
-0.19%
Sales Growth (3Y)
-0.48%
Sales Growth (5Y)
-0.28%
EPS Est (This Year)
$-11.95
EPS Est (Next Year)
$-14.65
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$21.99
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
4.04M
Float
3.58M
Free Float %
88.70%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
LSE
IPO Date
2018-01-29
Employees
225
CEO
Thane Wettig
Index Membership
—
Website
https://www.kyntrabio.com
Kyntra Bio, Inc. (0IL8.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $29.21M, a P/E ratio of -2.38, 0IL8.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0IL8.L against other stocks using dozens of fundamental and technical filters.
Kyntra Bio, Inc. (0IL8.L) has a trailing twelve-month (TTM) P/E ratio of -2.38. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Kyntra Bio, Inc. (0IL8.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Kyntra Bio, Inc. (0IL8.L) has a market capitalization of $29.21 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.